UNSPSC 51283206: Rokitamycin

This classification denotes a miocamycin analog and leucomycin with the molecular formula C42H69NO15, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZPT03UEM0E, chemically known as leucomycin v, 4(sup b)-butanoate 3(sup b)-propanoate but generally known as rokitamycin, which bears US NIH Compound Identifier 5282211. European Medicines Agency schedules Rokitamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10361MIG.

UNSPSC 51283206 Rokitamycin is a Commodity code that nominally identifies a specific antibiotic drug product, but recent state and local procurement activity under this code shows substantial divergence from the code name itself. State and local governments are actually soliciting a broad range of pharmaceutical and medical supply products—including naloxone, first aid supplies, generic multi-source pharmaceuticals, and over-the-counter products—rather than rokitamycin specifically. The issuing bodies span county health departments, municipal fire departments, state health and human services agencies, and cooperative purchasing consortia serving multiple state and local jurisdictions. Work under the code includes procurement of finished pharmaceutical products for emergency response and community health programs, direct-to-manufacturer prescription fulfillment arrangements, and bulk supply of medical and first aid consumables for public safety operations.

Activity concentrates in Florida, Texas, Minnesota, and multi-state cooperative purchasing frameworks. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries and FEMA-potential funding; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs for self-insured health plans; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the fire department rescue division, valued at approximately $700,000 and designated as a certified Small Local Business Enterprise set-aside with a 5 percent bid discount capped at $10,000; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon. The MMCAP procurement requires cGMP and Drug Supply Chain Security Act compliance, mandatory use of three authorized wholesalers, and pricing due March 26, 2026, with contracts effective July 1, 2026.